Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome

Clinical trial NCT07654114 · RECRUITING

Trial details

NCT number: NCT07654114
Sponsor: Connecta Therapeutics, S.L.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome (FXS)Fragile X Syndrome

Start date: 2026-05-21
Primary completion: 2027-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.